Quantum Biopharma (QNTM) Q1 2025 Earnings
QNTM·Reported May 14, 2025·After market close
Quantum Biopharma reported Q1 2025 revenue of $2.2M. Diluted EPS came in at $-1.41, missed the $-0.37 consensus by $1.04.
Revenue
$2.2Mmet estimate
Consensus: $2.2MDiluted EPS
$-1.41missed by $1.04
Consensus: $-0.37
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about Quantum Biopharma's Q1 2025 earnings report.
Quantum Biopharma (QNTM) reported Q1 2025 earnings on May 14, 2025 after market close.
Quantum Biopharma reported revenue of $2.2M and diluted EPS of $-1.41 for Q1 2025.
Revenue beat the consensus estimate of $2.2M by -. EPS missed the consensus estimate of $-0.37 by $1.04.